Global Orally Dissolving Film Drug Market Growth 2022-2028

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Orally Dissolving Film Drug Annual Sales 2017-2028
  • 2.1.2 World Current & Future Analysis for Orally Dissolving Film Drug by Geographic Region, 2017, 2022 & 2028
  • 2.1.3 World Current & Future Analysis for Orally Dissolving Film Drug by Country/Region, 2017, 2022 & 2028
• 2.2 Orally Dissolving Film Drug Segment by Type
  • 2.2.1 Orodispersible Film
  • 2.2.2 Oromucosal Film
• 2.3 Orally Dissolving Film Drug Sales by Type
  • 2.3.1 Global Orally Dissolving Film Drug Sales Market Share by Type (2017-2022)
  • 2.3.2 Global Orally Dissolving Film Drug Revenue and Market Share by Type (2017-2022)
  • 2.3.3 Global Orally Dissolving Film Drug Sale Price by Type (2017-2022)
• 2.4 Orally Dissolving Film Drug Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Drugstores
  • 2.4.3 Others
• 2.5 Orally Dissolving Film Drug Sales by Application
  • 2.5.1 Global Orally Dissolving Film Drug Sale Market Share by Application (2017-2022)
  • 2.5.2 Global Orally Dissolving Film Drug Revenue and Market Share by Application (2017-2022)
  • 2.5.3 Global Orally Dissolving Film Drug Sale Price by Application (2017-2022)

3 Global Orally Dissolving Film Drug by Company

• 3.1 Global Orally Dissolving Film Drug Breakdown Data by Company
  • 3.1.1 Global Orally Dissolving Film Drug Annual Sales by Company (2020-2022)
  • 3.1.2 Global Orally Dissolving Film Drug Sales Market Share by Company (2020-2022)
• 3.2 Global Orally Dissolving Film Drug Annual Revenue by Company (2020-2022)
  • 3.2.1 Global Orally Dissolving Film Drug Revenue by Company (2020-2022)
  • 3.2.2 Global Orally Dissolving Film Drug Revenue Market Share by Company (2020-2022)
• 3.3 Global Orally Dissolving Film Drug Sale Price by Company
• 3.4 Key Manufacturers Orally Dissolving Film Drug Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Orally Dissolving Film Drug Product Location Distribution
  • 3.4.2 Players Orally Dissolving Film Drug Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Orally Dissolving Film Drug by Geographic Region

• 4.1 World Historic Orally Dissolving Film Drug Market Size by Geographic Region (2017-2022)
  • 4.1.1 Global Orally Dissolving Film Drug Annual Sales by Geographic Region (2017-2022)
  • 4.1.2 Global Orally Dissolving Film Drug Annual Revenue by Geographic Region
• 4.2 World Historic Orally Dissolving Film Drug Market Size by Country/Region (2017-2022)
  • 4.2.1 Global Orally Dissolving Film Drug Annual Sales by Country/Region (2017-2022)
  • 4.2.2 Global Orally Dissolving Film Drug Annual Revenue by Country/Region
• 4.3 Americas Orally Dissolving Film Drug Sales Growth
• 4.4 APAC Orally Dissolving Film Drug Sales Growth
• 4.5 Europe Orally Dissolving Film Drug Sales Growth
• 4.6 Middle East & Africa Orally Dissolving Film Drug Sales Growth

5 Americas

• 5.1 Americas Orally Dissolving Film Drug Sales by Country
  • 5.1.1 Americas Orally Dissolving Film Drug Sales by Country (2017-2022)
  • 5.1.2 Americas Orally Dissolving Film Drug Revenue by Country (2017-2022)
• 5.2 Americas Orally Dissolving Film Drug Sales by Type
• 5.3 Americas Orally Dissolving Film Drug Sales by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Brazil

6 APAC

• 6.1 APAC Orally Dissolving Film Drug Sales by Region
  • 6.1.1 APAC Orally Dissolving Film Drug Sales by Region (2017-2022)
  • 6.1.2 APAC Orally Dissolving Film Drug Revenue by Region (2017-2022)
• 6.2 APAC Orally Dissolving Film Drug Sales by Type
• 6.3 APAC Orally Dissolving Film Drug Sales by Application
• 6.4 China
• 6.5 Japan
• 6.6 South Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 China Taiwan

7 Europe

• 7.1 Europe Orally Dissolving Film Drug by Country
  • 7.1.1 Europe Orally Dissolving Film Drug Sales by Country (2017-2022)
  • 7.1.2 Europe Orally Dissolving Film Drug Revenue by Country (2017-2022)
• 7.2 Europe Orally Dissolving Film Drug Sales by Type
• 7.3 Europe Orally Dissolving Film Drug Sales by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia

8 Middle East & Africa

• 8.1 Middle East & Africa Orally Dissolving Film Drug by Country
  • 8.1.1 Middle East & Africa Orally Dissolving Film Drug Sales by Country (2017-2022)
  • 8.1.2 Middle East & Africa Orally Dissolving Film Drug Revenue by Country (2017-2022)
• 8.2 Middle East & Africa Orally Dissolving Film Drug Sales by Type
• 8.3 Middle East & Africa Orally Dissolving Film Drug Sales by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers & Growth Opportunities
• 9.2 Market Challenges & Risks
• 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

• 10.1 Raw Material and Suppliers
• 10.2 Manufacturing Cost Structure Analysis of Orally Dissolving Film Drug
• 10.3 Manufacturing Process Analysis of Orally Dissolving Film Drug
• 10.4 Industry Chain Structure of Orally Dissolving Film Drug

11 Marketing, Distributors and Customer

• 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
• 11.2 Orally Dissolving Film Drug Distributors
• 11.3 Orally Dissolving Film Drug Customer

12 World Forecast Review for Orally Dissolving Film Drug by Geographic Region

• 12.1 Global Orally Dissolving Film Drug Market Size Forecast by Region
  • 12.1.1 Global Orally Dissolving Film Drug Forecast by Region (2023-2028)
  • 12.1.2 Global Orally Dissolving Film Drug Annual Revenue Forecast by Region (2023-2028)
• 12.2 Americas Forecast by Country
• 12.3 APAC Forecast by Region
• 12.4 Europe Forecast by Country
• 12.5 Middle East & Africa Forecast by Country
• 12.6 Global Orally Dissolving Film Drug Forecast by Type
• 12.7 Global Orally Dissolving Film Drug Forecast by Application

13 Key Players Analysis

• 13.1 GSK
  • 13.1.1 GSK Company Information
  • 13.1.2 GSK Orally Dissolving Film Drug Product Offered
  • 13.1.3 GSK Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.1.4 GSK Main Business Overview
  • 13.1.5 GSK Latest Developments
• 13.2 LTS
  • 13.2.1 LTS Company Information
  • 13.2.2 LTS Orally Dissolving Film Drug Product Offered
  • 13.2.3 LTS Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.2.4 LTS Main Business Overview
  • 13.2.5 LTS Latest Developments
• 13.3 J&J
  • 13.3.1 J&J Company Information
  • 13.3.2 J&J Orally Dissolving Film Drug Product Offered
  • 13.3.3 J&J Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.3.4 J&J Main Business Overview
  • 13.3.5 J&J Latest Developments
• 13.4 Indivior
  • 13.4.1 Indivior Company Information
  • 13.4.2 Indivior Orally Dissolving Film Drug Product Offered
  • 13.4.3 Indivior Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.4.4 Indivior Main Business Overview
  • 13.4.5 Indivior Latest Developments
• 13.5 Pfizer
  • 13.5.1 Pfizer Company Information
  • 13.5.2 Pfizer Orally Dissolving Film Drug Product Offered
  • 13.5.3 Pfizer Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.5.4 Pfizer Main Business Overview
  • 13.5.5 Pfizer Latest Developments
• 13.6 Sanofi
  • 13.6.1 Sanofi Company Information
  • 13.6.2 Sanofi Orally Dissolving Film Drug Product Offered
  • 13.6.3 Sanofi Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.6.4 Sanofi Main Business Overview
  • 13.6.5 Sanofi Latest Developments
• 13.7 Church & Dwight
  • 13.7.1 Church & Dwight Company Information
  • 13.7.2 Church & Dwight Orally Dissolving Film Drug Product Offered
  • 13.7.3 Church & Dwight Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.7.4 Church & Dwight Main Business Overview
  • 13.7.5 Church & Dwight Latest Developments
• 13.8 tesa Labtec
  • 13.8.1 tesa Labtec Company Information
  • 13.8.2 tesa Labtec Orally Dissolving Film Drug Product Offered
  • 13.8.3 tesa Labtec Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.8.4 tesa Labtec Main Business Overview
  • 13.8.5 tesa Labtec Latest Developments
• 13.9 Tapemark
  • 13.9.1 Tapemark Company Information
  • 13.9.2 Tapemark Orally Dissolving Film Drug Product Offered
  • 13.9.3 Tapemark Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.9.4 Tapemark Main Business Overview
  • 13.9.5 Tapemark Latest Developments
• 13.10 Prestige
  • 13.10.1 Prestige Company Information
  • 13.10.2 Prestige Orally Dissolving Film Drug Product Offered
  • 13.10.3 Prestige Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.10.4 Prestige Main Business Overview
  • 13.10.5 Prestige Latest Developments
• 13.11 Sun Pharma
  • 13.11.1 Sun Pharma Company Information
  • 13.11.2 Sun Pharma Orally Dissolving Film Drug Product Offered
  • 13.11.3 Sun Pharma Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.11.4 Sun Pharma Main Business Overview
  • 13.11.5 Sun Pharma Latest Developments
• 13.12 MonoSol
  • 13.12.1 MonoSol Company Information
  • 13.12.2 MonoSol Orally Dissolving Film Drug Product Offered
  • 13.12.3 MonoSol Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.12.4 MonoSol Main Business Overview
  • 13.12.5 MonoSol Latest Developments
• 13.13 BioDelivery
  • 13.13.1 BioDelivery Company Information
  • 13.13.2 BioDelivery Orally Dissolving Film Drug Product Offered
  • 13.13.3 BioDelivery Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.13.4 BioDelivery Main Business Overview
  • 13.13.5 BioDelivery Latest Developments
• 13.14 Arx
  • 13.14.1 Arx Company Information
  • 13.14.2 Arx Orally Dissolving Film Drug Product Offered
  • 13.14.3 Arx Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.14.4 Arx Main Business Overview
  • 13.14.5 Arx Latest Developments
• 13.15 ZIM
  • 13.15.1 ZIM Company Information
  • 13.15.2 ZIM Orally Dissolving Film Drug Product Offered
  • 13.15.3 ZIM Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.15.4 ZIM Main Business Overview
  • 13.15.5 ZIM Latest Developments
• 13.16 NAL Pharma
  • 13.16.1 NAL Pharma Company Information
  • 13.16.2 NAL Pharma Orally Dissolving Film Drug Product Offered
  • 13.16.3 NAL Pharma Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.16.4 NAL Pharma Main Business Overview
  • 13.16.5 NAL Pharma Latest Developments
• 13.17 AdhexPharma
  • 13.17.1 AdhexPharma Company Information
  • 13.17.2 AdhexPharma Orally Dissolving Film Drug Product Offered
  • 13.17.3 AdhexPharma Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.17.4 AdhexPharma Main Business Overview
  • 13.17.5 AdhexPharma Latest Developments
• 13.18 Aavishkar
  • 13.18.1 Aavishkar Company Information
  • 13.18.2 Aavishkar Orally Dissolving Film Drug Product Offered
  • 13.18.3 Aavishkar Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.18.4 Aavishkar Main Business Overview
  • 13.18.5 Aavishkar Latest Developments
• 13.19 IntelGenx Corp
  • 13.19.1 IntelGenx Corp Company Information
  • 13.19.2 IntelGenx Corp Orally Dissolving Film Drug Product Offered
  • 13.19.3 IntelGenx Corp Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.19.4 IntelGenx Corp Main Business Overview
  • 13.19.5 IntelGenx Corp Latest Developments
• 13.20 APR
  • 13.20.1 APR Company Information
  • 13.20.2 APR Orally Dissolving Film Drug Product Offered
  • 13.20.3 APR Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.20.4 APR Main Business Overview
  • 13.20.5 APR Latest Developments

14 Research Findings and Conclusion